 |
|
Sclerosing MesenteritisResponse to Cyclophosphamide
Roger W. Bush, MD;
Samuel P. Hammar, Jr, MD;
Robert H. Rudolph, MD
Arch Intern Med. 1986;146(3):503-505.
Abstract
• We present two patients with an aggressive form of sclerosing mesenteritis characterized by (1) a progressive, lifethreatening course, (2) prominent retroperitoneal disease, and (3) tubuloreticular structures in one case, an ultrastructural feature associated with autoimmune and cyclophosphamideresponsive diseases. In both patients, aggressive immunosuppressive medical therapy with cyclophosphamide resulted in prompt, dramatic improvement, without recurrence. When the diagnosis of sclerosing mesenteritis is established, we recommend early aggressive medical therapy with cyclophosphamide, particularly when tubuloreticular structures are present.
(Arch Intern Med 1986;146:503-505)
Author Affiliations
From the Departments of Medicine (Drs Bush and Rudolph) and Pathology (Dr Hammar), the Mason Clinic, Seattle.
Footnotes
Accepted for publication June 19, 1985.
Reprints not available.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
An unusual presentation of sclerosing mesenteritis mimicking inflammatory bowel disease in a teenager.
Parampalli et al.
J R Soc Med Sh Rep 2011;2:16-16.
FULL TEXT
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases
Schaffler et al.
Endocr Rev 2006;27:449-467.
ABSTRACT
| FULL TEXT
Mesenteric panniculitis associated with abdominal tuberculous lymphadenitis: a case report and review of the literature
Ege et al.
Br. J. Radiol. 2002;75:378-380.
ABSTRACT
| FULL TEXT
CT Evaluation of Mesenteric Panniculitis: Prevalence and Associated Diseases
Daskalogiannaki et al.
Am. J. Roentgenol. 2000;174:427-431.
ABSTRACT
| FULL TEXT
|
